Arkolith/Insider Trading/PSTX/Form 4

Malin Life Sciences Holdings Ltd

10% OwnerPoseida Therapeutics, Inc. (PSTX) · full profile →Form 4 · filed Jan 10, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 8, 2025Tender(U)11.8M——0

Transaction Codes

U
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-002540) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML